Clinical trial
Pulmonary Epithelium, Immunology and Development of Asthma: Breathing Together
NCT04063631
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedPulmonary Epithelium, Immunology and Development of Asthma: Breathing Together
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Wheezingunresolved
Interventions
Sponsors & collaborators
Imperial College Londonlead sponsor
Queen Mary University of Londoncollaborator
University of Bristolcollaborator
University of Southamptoncollaborator
University of Edinburghcollaborator
Queen's University, Belfastcollaborator
University of Aberdeencollaborator
Monash Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04063631 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.